Display options
Cite
O'Donnell JA. Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?. Curr Infect Dis Rep. 1999;1(2):142-147doi: 10.1007/s11908-996-0021-9.
O'Donnell, J. A. (1999). Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?. Current infectious disease reports, 1(2), 142-147. https://doi.org/10.1007/s11908-996-0021-9
O'Donnell. "Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?." Current infectious disease reports vol. 1,2 (1999): 142-147. doi: https://doi.org/10.1007/s11908-996-0021-9
O'Donnell JA. Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?. Curr Infect Dis Rep. 1999 Jun;1(2):142-147. doi: 10.1007/s11908-996-0021-9. PMID: 11095780.
Copy Download .nbib Format: NLM
Share it on

Curr Infect Dis Rep. 1999 Jun;1(2):142-147. doi: 10.1007/s11908-996-0021-9.

Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?.

Current infectious disease reports

O'Donnell

Affiliations

  1. Division of Infectious Diseases, MCP Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA.

PMID: 11095780 DOI: 10.1007/s11908-996-0021-9

Abstract

The possibility that infection with Chlamydia pneumoniae may somehow contribute to the pathogenesis of atherosclerosis continues to be explored by researchers worldwide. A direct cause-and-effect relationship between the bacterium and subsequent development of atherosclerosis has yet to be proved. However, compelling indirect evidence continues to mount in favor of this association. In this article the most recent information on this topic is reviewed. Seroepidemiologic and histopathologic evidence will be highlighted, as well as recent animal models of infection and atherosclerosis. In addition, current studies looking at the association of antichlamydial antibiotic use and risk of adverse cardiovascular outcomes will be detailed.

References

  1. J Infect Dis. 1998 May;177(5):1322-5 - PubMed
  2. Infect Immun. 1997 Nov;65(11):4832-5 - PubMed
  3. Lancet. 1988 Oct 29;2(8618):983-6 - PubMed
  4. Lancet. 1998 Jun 20;351(9119):1858-9 - PubMed
  5. Arterioscler Thromb. 1993 Oct;13(10):1501-4 - PubMed
  6. Emerg Infect Dis. 1999 Mar-Apr;5(2):281-4 - PubMed
  7. Lancet. 1997 Aug 9;350(9075):430-6 - PubMed
  8. Microbiol Rev. 1994 Dec;58(4):686-99 - PubMed
  9. Ann Intern Med. 1992 Feb 15;116(4):273-8 - PubMed
  10. J Infect Dis. 1996 Apr;173(4):957-62 - PubMed
  11. Ann Intern Med. 1996 Dec 15;125(12):979-82 - PubMed
  12. BMJ. 1997 Jun 21;314(7097):1778-9 - PubMed
  13. J Exp Med. 1978 Jul 1;148(1):335-40 - PubMed
  14. J Clin Microbiol. 1995 Sep;33(9):2411-4 - PubMed
  15. Cardiovasc Res. 1994 Sep;28(9):1301-11 - PubMed
  16. Microb Pathog. 1994 Apr;16(4):313-9 - PubMed
  17. Blood. 1997 Jul 1;90(1):1-11 - PubMed
  18. Circulation. 1997 Jul 15;96(2):404-7 - PubMed
  19. JAMA. 1999 Feb 3;281(5):427-31 - PubMed
  20. S Afr Med J. 1992 Sep;82(3):158-61 - PubMed
  21. Infect Immun. 1996 May;64(5):1614-20 - PubMed
  22. J Am Coll Cardiol. 1998 May;31(6):1217-25 - PubMed
  23. J Clin Microbiol. 1997 Jan;35(1):48-52 - PubMed
  24. J Infect Dis. 1997 Apr;175(4):883-90 - PubMed
  25. J Infect Dis. 1994 Aug;170(2):464-7 - PubMed
  26. Circulation. 1993 Apr;87(4):1130-4 - PubMed
  27. Lancet. 1997 Aug 9;350(9075):404-7 - PubMed
  28. Nature. 1993 Apr 29;362(6423):801-9 - PubMed
  29. J Antimicrob Chemother. 1998 Jan;41(1):85-92 - PubMed
  30. J Infect Dis. 1993 Apr;167(4):841-9 - PubMed
  31. Microb Pathog. 1996 Sep;21(3):215-21 - PubMed
  32. J Am Coll Cardiol. 1996 Jun;27(7):1555-61 - PubMed
  33. J Infect Dis. 1997 Jul;176(1):292-5 - PubMed
  34. J Investig Med. 1997 Apr;45(4):168-74 - PubMed
  35. J Infect Dis. 1995 Aug;172(2):585-8 - PubMed

Publication Types